Alpha 2.0
Login Register
» Journals » Haematologica

Haematologica

Haematologica is a renowned international journal dedicated to the field of hematology. It publishes high-quality research articles, reviews, and case reports covering various aspects of blood disorders, including leukemia, lymphoma, myeloma, and other hematological malignancies. With a focus on advancing knowledge and promoting excellence in clinical and experimental hematology, Haematologica serves as a valuable resource for hematologists, researchers, and healthcare professionals worldwide.
Details
Abbr. Haematologica
Start 1920
End Continuing
Frequency Monthly, 1998-
p-ISSN 0390-6078
e-ISSN 1592-8721
Country Italy
Languages English
Italian
Specialty Hematology
Metrics
h-index / Ranks: 1163 165
SJR / Ranks: 828 2490
CiteScore / Ranks: 778 13.30
JIF / Ranks: 453 10.1
Recent Articles
1.
Impact of hematopoietic cell transplantation and quizartinib in newly diagnosed patients with acute myeloid leukemia and FMS-like tyrosine kinase 3-internal tandem duplications in the QuANTUM-First trial
Schlenk R, Montesinos P, Kim H, Romero-Aguilar A, Vrhovac R, Patkowska E, et al.
Haematologica . 2025 Mar; PMID: 40079105
QuANTUM-First (NCT02668653) was a randomized phase 3 trial in newly diagnosed FLT3-ITDQpositive acute myeloid leukemia (AML) patients treated with quizartinib or placebo plus standard induction and consolidation chemotherapy and/or allogeneic...
2.
Hemophilia is associated with accelerated biological aging
Trappl M, Vostatek R, Salzmann M, Kraemmer D, Gebhart J, Hohensinner P, et al.
Haematologica . 2025 Mar; PMID: 40079104
Hemophilia is a rare X-linked bleeding disorder caused by mutations in the F8 or F9 gene (hemophilia A or B), leading to deficient factor VIII or IX proteins, respectively. Hemophilia-related...
3.
Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up
Portuguese A, Huang J, Jeon Y, Taheri M, Albittar A, Liang E, et al.
Haematologica . 2025 Mar; PMID: 40079097
Lisocabtagene maraleucel (liso-cel) and axicabtagene ciloleucel (axi-cel) are FDA- and EMAapproved chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory large B-cell lymphoma (LBCL). However, comparative real-world analyses of their efficacy...
4.
Regulation of immune responses to therapeutic factor VIII by transplacental delivery of Fc-fused immunodominant factor VIII domains or peptides
Reyes-Ruiz A, Delignat S, Azam A, Daventure V, Dourthe L, Mimoun A, et al.
Haematologica . 2025 Mar; PMID: 40079095
Patients with severe hemophilia A (HA) often develop undesired immune responses to therapeutic factor VIII (FVIII) that hamper replacement therapy with FVIII-derived products. The transplacental delivery of two Fc-fused FVIII...
5.
Safe platelet count for lumbar puncture: are we being overcautious?
Badar T
Haematologica . 2025 Mar; PMID: 40079093
Not available.
6.
Plasma exchange for hyperammonemia-induced reduced consciousness after PEG-asparaginase in an adult patient with acute lymphoblastic leukemia
Klingler F, Forstreuter A, Stegat L, Kamereit S, Ullrich F, Udonta F, et al.
Haematologica . 2025 Mar; PMID: 40079089
Not available.
7.
Exploring new horizons in menin: it's bleximenib's turn
Rockwell B, Konopleva M
Haematologica . 2025 Mar; PMID: 40079087
Not available.
8.
Bruton tyrosine kinase covalent inhibition shapes the immune microenvironment in chronic lymphocytic leukemia
Medina-Gil D, Palomo L, Navarro V, Lazaro G, Martin-Mur B, Hernandez C, et al.
Haematologica . 2025 Mar; PMID: 40079085
Continuous treatment with ibrutinib not only exerts tumor control but also enhances T cell function in patients with chronic lymphocytic leukemia (CLL). We conducted longitudinal multi-omics analyses in samples from...
9.
Enforcement of stem-cell dormancy by nucleophosmin mutation is a critical determinant of unrestricted self-renewal during myeloid leukemogenesis
Merlo M, Mallardo M, Luzi L, De Conti G, Caprioli C, Hillje R, et al.
Haematologica . 2025 Mar; PMID: 40079083
Mutations in the NPM1 gene (NPMc+) and in the FLT3 gene (FLT3-ITD) represent the most frequent co-occurring mutations in Acute Myeloid Leukemia (AML), yet the cellular and molecular mechanisms of...
10.
Leukemic presentation in nodal mantle cell lymphoma is characterized by frequent SOX11 negativity, a poor risk genomic landscape including higher alterations, and worse overall survival
Yan M, Sethi S, Kumar J, Kumar A, Dogan A, Galera P
Haematologica . 2025 Mar; PMID: 40079077
Not available.